Research and Markets, the largest resource for market research information in world providing essential market research reports, industry research, industry analysis, forecasts, market studies, company profiles and country reports.
Welcome - Home - Register - Login - Help/FAQ - 0 items View Basket
Worlds Largest Market Research Resource - 722272 Live Reports
Search Research and Markets
  Search
Enter keywords, a title or
a report id number below.





Advanced   
Register for free email updates of market research
Currency
  Select a currency for use throughout the site



Search Results

Your Search for 'Cancer and Neoplasms in Spain' returned 21 results - Page 1 of 2

 FEATURED RESULTS
Cancer Stem Cells: Emerging Therapeutic, Diagnostic and Mark...

Drug Delivery in Cancer - Technologies, Markets and Companies

Apoptosis in Oncology: Drug Pipeline Update 2008

Cancer Diagnostic Testing World Markets

Antibody Drug Target Atlas in Oncology


  Sort by   
  Sorted by Rank Top-Bottom

Commercial Insight: Targeted Therapy Cancer Brands - High Growth Market will see Eight New Blockbusters by 2017  
Datamonitor, July 2008, Pages: 272
... Analysis of future market 145 Spain 147 Analysis ... by indication 156 Solid tumors versus
hematological malignancies 156 Targeted therapy cancer brands approved ...


Gastric Cancer - Targeted Therapies Compete for First-to-Market Status  
Datamonitor, April 2009, Pages: 76
... markets (US, Japan, Germany, France, Italy, Spain, and UK). ... Surgical Staging System
for gastric cancer Table 15 ... 0 classification of early gastric tumors Table 16 ...


Ovarian Cancer Therapeutics - Global Strategic Business Report  
Global Industry Analysts, Inc., Feb 2006, Pages: 248
... II-5 Germ-Cell Tumors II-5 Stromal Tumors II-5 ... Cancer III-11 Table 9: Ovarian Cancer
Incidence in ... Germany, Russia, UK, Italy and Spain (includes corresponding ...


Stakeholder Insight: Supportive Care in Cancer Treatment - Some First-Generation Products Proving Difficult to Dislodge  
Datamonitor, Oct 2006, Pages: 233
... seven major pharmaceutical markets (solid tumors) 48 Table 5 ... the prophylaxis and
treatment of cancer-related skeletal ... 2006 186 Table 64: Spain physician sample ...


Prostate Cancer - A Prostrate Market Waiting For Innovations  
Datamonitor, Oct 2005, Pages: 312
... be used in a level similar to that seen in other tumors. ... Scope 13 The prostate 14
Prostate cancer 14 Histology 15 ... 23 France 26 Germany 29 Italy 32 Spain 35 UK ...


Stakeholder Insight: Prostate Cancer - Hormone-Refractory Patients Still Waiting For Treatment Breakthroughs  
Datamonitor, Dec 2007, Pages: 249
... 69 ...however, in Spain and Japan, total androgen ... initial treatment approach for
localized prostate cancer 69 Anti ... used drug regimen for localized tumors due to ...


Breast Cancer Insight - Defining Drug Decisions - How Can Companies Influence the Treatment of Breast Cancer?  
Datamonitor, April 2002, Pages: 548
... the US, Japan, France, Germany, Italy, Spain and the ... Diagnosing the biological
characteristics of tumors THERAPEUTIC APPROACHES TO BREAST CANCER <BR ...


Cytogenetics - Technologies, Markets and Companies  
Jain PharmaBiotech, Nov 2009, Pages: 200
... US, Western Europe (including France, Germany, Italy, Spain, and the UK ... Bone and
soft tissue tumors Brain tumors Breast cancer Chromosomal aberrations in ...


Pipeline/Commercial Insight: Colorectal Cancer - Shaping the Future Dynamics of Colorectal Cancer Management  
Datamonitor, Oct 2006, Pages: 167
... US, Western Europe (including France, Germany, Italy, Spain, and the UK ... Bone and
soft tissue tumors Brain tumors Breast cancer Chromosomal aberrations in ...


Brain Cancer Drug Pipeline Update 2009  
Bioseeker, Jan 2009
... cancer to 2015 141 Table 40: Spain forecasts for ... and five-year cumulative prevalence
of colorectal cancer in the ... rates for the four major tumors between 1975 ...


Stakeholder Insight: Herceptin, The First of the Innovative Therapies  
Datamonitor, Feb 2003, Pages: 196
... brain cancer research, primary brain cancer, with glioblastoma ... While primary brain
tumors are relatively rare, the ... Japan, France, Germany, Italy, Spain and UK ...


The 2007-2012 World Outlook for Pharmaceutical Preparations for Human Use Affecting Neoplasms, the Endocrine System, and Metabolic Diseases  
ICON Group International, May 2006, Pages: 196
... THE BIOLOGICAL CHARACTERISTICS OF BREAST TUMORS <BR ...


The 2007-2012 World Outlook for Pharmaceuticals Affecting Neoplasms, the Endocrine System, and Metabolic Diseases  
ICON Group International, May 2006, Pages: 201
... and metabolic diseases 3254121111 cancer therapy pharmaceuticals ... for human use affecting
neoplasms, the endocrine system ... South Africa 943.99 Spain 953.100 Sudan ...


Pipeline/Commercial Insight: Molecular Targeted Cancer Therapies - More Drugs on the Market, More Targets in the Pipeline  
Datamonitor, Oct 2006, Pages: 430
... metabolic diseases 3254121111 cancer therapy pharmaceuticals ... to demand pharmaceuticals
affecting neoplasms, the endocrine ... Slovenia 1175.40 Spain 1185.41 Sweden ...


Commercial Insight: Cytotoxic Therapies - Market growth will slow due to increasing genericization  
Datamonitor, June 2009, Pages: 127
... Phenoxodiol plus Taxotere in ovarian cancer 294 Phenoxodiol ... for a variety of solid
tumors 294 OurComments ... Forecasts 379 Italy Forecasts 380 Spain Forecasts 381 ...


Brachytherapy - Global Strategic Business Report  
Global Industry Analysts, Inc., July 2009, Pages: 227
... of Taxol in a variety of solid tumors resulted in ... 12: Cytotoxic therapy sales ($m)
in Spain, 2008-2018 ... of brand choice for cytotoxic therapy in cancer Figure 16 ...


Post-Genomic Biomarkers: Revolutionizing Drug Development and Diagnostics 2nd Edition  
Drug and Market Development Publishing, March 2005, Pages: 211
... II-28 Brachytherapy for Eyelid Tumors II-28 ... Nucletron Introduces Oncentra® Brachy
Cancer Treatment Solution ... Radiation Therapy Products to Spanish Hospitals II ...


Top 20 Therapy Cancer Brands - Key Brands Set to Consolidate Advantage as Competition Intensifies  
Datamonitor, Aug 2008, Pages: 401
... 10?14 Michael Spain, MD, Chief Medical Officer ... promise is particularly strong for
cancer diagnostics ... The heterogeneity of malignant tumors often calls for multi ...


Innovative Targeted Therapies - Smart Drugs On Target For Increasing Growth  
Datamonitor, Oct 2005, Pages: 348
... 145 Opportunities 145 Threats 146 Spain 149 Current ... market 182 Global targeted therapy
cancer brands market ... by indication 186 Solid tumors versus hematological ...


Cell Therapy - Technologies, Markets and Companies  
Jain PharmaBiotech, Nov 2009, Pages: 935
... provides incremental benefit in selected tumors 57 Optimizing ... Pipeline overview 189
National Cancer Institute?s ... 286 Italy forecasts 287 Spain forecasts 288 ...


Results:  First -   Prev -   1 -   2 -   Next -   Last


Top of page


   All rights reserved. © Copyright 2009 Research and Markets
   Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster


Research and Markets RSS Feeds